New Delhi Metallo-Beta-Lactamase (NDM-1)-Producing Klebsiella Pneumoniae Isolated from a Burned Patient

Santiago Petersen-Morfin1, Paola Bocanegra-Ibarias2, Rayo Morfin-Otero1,3

  • 1Civil Hospital of Guadalajara, Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.

Insights

Burn patients face severe infections from resistant bacteria like Klebsiella pneumoniae. This case highlights the critical need for effective antibiotic strategies against multidrug-resistant pathogens in immunocompromised individuals.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Burn patients are susceptible to healthcare-associated infections (HAIs) caused by common pathogens.
  • Antibiotic resistance, particularly carbapenemase production, complicates treatment of these infections.
  • Emergence of multidrug-resistant (MDR) bacteria poses a significant threat in clinical settings.

Observation:

  • A case report details a burn patient with polymicrobial HAIs.
  • The patient developed a bloodstream infection with New Delhi metallo-beta-lactamase (NDM-1)-producing Klebsiella pneumoniae.
  • Treatment challenges arose with MDR Pseudomonas aeruginosa and NDM-1 positive K. pneumoniae isolates.

Findings:

  • Initial antibiotic regimens were partially effective against some pathogens.
  • Subsequent bacterial isolates exhibited MDR, necessitating complex antibiotic combinations.
  • The patient's clinical status worsened despite intensive treatment.

Implications:

  • This case underscores the necessity of robust antibiotic stewardship in managing burn wound infections.
  • Vigilance for emergent carbapenemase-producing MDR bacteria in burn patients is crucial.
  • Early identification and tailored therapy are vital for improving outcomes in critically ill patients.